Current Heart Failure Reports

, Volume 8, Issue 1, pp 72–79

Recognition and Management of Sleep-Disordered Breathing in Chronic Heart Failure


DOI: 10.1007/s11897-010-0037-1

Cite this article as:
Kahwash, R., Kikta, D. & Khayat, R. Curr Heart Fail Rep (2011) 8: 72. doi:10.1007/s11897-010-0037-1


It is increasingly recognized that sleep-disordered breathing (SDB) is a common modifiable risk factor for cardiovascular disease with significant impact on morbidity and potentially mortality. SDB is highly prevalent in patients with systolic or diastolic heart failure. A high index of suspicion is necessary to diagnose SDB in patients with heart failure because the vast majority of affected patients do not report daytime symptoms. Recent clinical trials have demonstrated improvement in heart function, exercise tolerance, and quality of life after treatment of SDB in patients with heart failure. Accumulating evidence suggests that treatment of SDB should complement the established pharmacologic therapy for chronic heart failure. However, mortality benefit has yet to be demonstrated.


Obstructive sleep apneaCentral sleep apneaChronic systolic heart failureRespirationPositive airway pressure

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Division of Cardiovascular Medicine, Section of Heart Failure and TransplantDavis Heart/Lung Research InstituteColumbusUSA
  2. 2.Division of Cardiovascular Medicine, Section of Heart Failure and Transplant, The Sleep Heart ProgramDavis Heart/Lung Research InstituteColumbusUSA